Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Erectile Dysfunction Drug Shows Mixed Results in Alzheimer's

(MedPage Today) -- Mirodenafil (known as AR1001), an oral phosphodiesterase-5 inhibitor approved in South Korea to treat erectile dysfunction, showed mixed results in people with early Alzheimer's disease in the phase III POLARIS-AD trial. The...

Erectile Dysfunction Drug Shows Mixed Results in Alzheimer's

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 17 November →